Department of Applied Chemistry, Faculty of Textile Technology, University of Zagreb, baruna Filipovića 10000 Zagreb, Croatia.
Bioorg Med Chem. 2010 Feb;18(3):1038-44. doi: 10.1016/j.bmc.2009.12.054. Epub 2009 Dec 29.
The efficient synthesis of new bis-substituted nitro-amidino, amino-amidino (10a, 10b-13a, 13b) and previously prepared diamidino 2-phenyl-benzothiazoles (9a, 9b) is described. The compounds 11a and 11b were prepared by recently developed methodology of the key precursors in zwitterionic form 8a and 8b with 4-nitrobenzoylchloride in a very good yield (70%). All compounds except diamidino-substituted 2-phenylbenzothiazole 9a show exceptionally prominent tumor cell-growth inhibitory activity and cytotoxicity, whereby the special selectivity of amino-amidine 2-phenylbenzothiazole 12a towards MCF-7 and H 460 cells makes this compound a prospective lead compound that should be further evaluated in animal models. All in vivo tested compounds (12a, 12b, 13a and 13b) are absorbed from mice gastrointestinal system. LD(50) are between 67.33 and 696.2mg/kg body weight (OECD/EPA toxicity categories 2-3).
新的双取代硝基酰胺基、氨基酰胺基(10a、10b-13a、13b)和以前制备的二酰胺基 2-苯基苯并噻唑(9a、9b)的高效合成方法已经描述。化合物 11a 和 11b 是通过最近开发的关键前体 8a 和 8b 的两性离子形式与 4-硝基苯甲酰氯反应,以非常好的收率(70%)制备的。除了二酰胺基取代的 2-苯基苯并噻唑 9a 之外,所有化合物都表现出异常显著的肿瘤细胞生长抑制活性和细胞毒性,其中氨基酰胺基 2-苯基苯并噻唑 12a 对 MCF-7 和 H 460 细胞的特殊选择性使该化合物成为有前途的先导化合物,应该在动物模型中进一步评估。所有在体内测试的化合物(12a、12b、13a 和 13b)都从小鼠胃肠道系统中被吸收。LD(50)在 67.33 至 696.2mg/kg 体重之间(OECD/EPA 毒性类别 2-3)。